NCR Atleos Corp financial statements

Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data NCR Atleos Corp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2021	FY2023	FY2023	FY2024	FY2025
Revenue	3,549	4,122	4,186	4,305	4,354
Research and development	107	64	80	62	70
Selling, general and administrative	537	586	585	521	513
Operating income	248	258	263	437	478
Interest expense		31	90	309	270
Interest income	0	0	5	7
Other non-operating income	52	-81	-84	21	-19
Pre-tax income	251	146	89	125	189
Income tax	64	48	237	44	27
Income from continuing operations	186	99	-150	80	162
Net income to minority interests	1	-1	2	1	0
Net income	186	99	-150	80	162
EBITDA	320	385	517	724	755
EPS, basic	2.41	1.40	-2.12	1.11	2.20
EPS, diluted	2.41	1.40	-2.12	1.08	2.14
Shares, basic (weighted)	77.2	70.6	70.6	72.2	73.5
Shares, diluted (weighted)	77.2	70.6	70.6	74.2	75.6

Balance sheet

	FY2021	FY2023	FY2023	FY2024	FY2025
Cash and equivalents	238	293	339	419	456
Receivables		455	707	581	550
Inventory		419	333	307	342
Other current assets		231	244	232	301
Total current assets		1,649	1,861	1,749	1,824
Property, plant and equipment		412	468	474	511
Lease right-of-use assets		85	144	144	177
Goodwill	1,906	1,949	1,952	1,950	1,958
Intangible assets		729	635	550	498
Other non-current assets		123	169	156	153
Total assets		5,772	5,702	5,535	5,668
Accounts payable		350	505	564	617
Accrued liabilities		69	149	145	139
Deferred revenue		356	332	328	383
Short-term debt		108	76	81	86
Total current liabilities		1,369	1,773	1,722	1,899
Long-term debt		717	2,938	2,859	2,672
Lease liabilities		59	109	110	139
Other non-current liabilities		103	141	120	135
Total liabilities		2,510	5,480	5,312	5,266
Total debt		717	3,099	2,859	2,672
Paid-in capital		0	12	47	65
Retained earnings		0	117	188	299
Other comprehensive income		-63	89	-17	38
Shareholders' equity		3,263	219	219	403
Minority interests		-1	3	4	-1
Total equity	2,333	3,250	222	223	402
Total liabilities and equity		5,772	5,702	5,535	5,668
Shares outstanding		70.9	70.9	72.7	73.7

Cash flow statement

	FY2021	FY2023	FY2023	FY2024	FY2025
Net income	187	98	-148	81	162
Depreciation and amortization	72	127	254	287	277
Stock-based compensation	82	66	68	38	34
Deferred income tax	19	-28	74	-19	-1
Change in inventory	-136	-10	53	-77	-97
Cash from operations	449	274	355	344	356
Capital expenditures	-80	-58	-108	-87	-117
Acquisitions	-2,346	-78	-1	0	-17
Purchases of investments	0	0	-10	-1
Sales and maturities of investments		0	0	5
Cash from investing	-2,493	-417	-316	-135	-116
Debt issued	0	0	1,333	0	0
Share buybacks			0	0	-28
Cash from financing	2,345	183	31	-134	-253
Exchange rate effect	-1	-11	17	-20	16
Net change in cash	300	29	87	55	3
Free cash flow	369	216	247	257	239
Income taxes paid	42	32	69	54	83

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $46.08 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	11.5%	Operating income / revenue.
EBITDA margin	17.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	5.3%	Pre-tax income / revenue.
Net margin	4.4%	Net income / revenue.
FCF margin	3.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	6.3%	Cash from operations / revenue.
Effective tax rate	15.0%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	42.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	3.5%	Net income / average total assets.
Return on invested capital (ROIC)	15.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	1.7%	Research and development expense / revenue.
SG&A / revenue	12.2%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.8%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.7%	Capital expenditures / revenue.
D&A / revenue	6.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	1.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	1.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income growth, 1y	9.4%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	22.8%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	4.3%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	25.2%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	102.5%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	17.8%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	98.1%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	15.2%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	3.5%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	9.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow growth, 1y	-7.0%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	3.4%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y	84.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-50.2%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y	2.4%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-0.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y	1.9%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	2.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.03x	Current assets / current liabilities.
Quick ratio	0.57x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.24x	(Cash + short-term investments) / current liabilities.
Debt / equity	5.84x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	47.9%	Total debt / total assets.
Liabilities / assets	91.8%	Total liabilities / total assets.
Net debt	$2.28B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.91x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	1.95x	Operating income / interest expense.
Working capital	$46.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	42.5%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$1.94B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.78x	Revenue / average total assets.
Fixed asset turnover	8.43x	Revenue / average property, plant and equipment.
Receivables turnover	7.35x	Revenue / average receivables.
Days sales outstanding	50 days	365 x average receivables / revenue.
FCF conversion	81.1%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	43.0%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.58	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$58.30	Revenue / diluted weighted shares.
FCF per share	$2.10	Free cash flow / diluted weighted shares.
Operating cash flow per share	$3.68	Cash from operations / diluted weighted shares.
Book value per share	$6.29	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$26.34	Tangible book value / shares outstanding.
Cash per share	$5.81	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$3.41B	Share price x shares outstanding.
Enterprise value	$5.69B	Market cap + total debt - cash - short-term investments.
P/E	17.4x	Market cap / net income. Only when net income is positive.
P/S	0.77x	Market cap / revenue.
P/B	7.34x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	21.4x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	12.2x	Market cap / cash from operations, when positive.
EV/Sales	1.29x	Enterprise value / revenue.
EV/EBIT	11.2x	Enterprise value / operating income, when both are positive.
EV/EBITDA	7.25x	Enterprise value / EBITDA, when both are positive.
EV/FCF	35.8x	Enterprise value / free cash flow, when both are positive.
FCF yield	4.7%	Free cash flow / market cap.
Earnings yield	5.8%	Net income / market cap (the inverse of P/E).
PEG	1.14x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was NCR Atleos Corp's revenue in fiscal 2025?

NCR Atleos Corp reported revenue of $4.35B for fiscal 2025, 1.1% higher than the year before.

Was NCR Atleos Corp profitable in fiscal 2025?

Yes. Net income was $162.0M, a net margin of 3.7%.

How much free cash flow did NCR Atleos Corp generate in fiscal 2025?

Cash from operations of $356.0M minus capital expenditures of $117.0M left free cash flow of $239.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to NCR Atleos Corp